VERFAHREN ZUR INHIBIERUNG DER WIRKUNG DES MENSCHLICHEN IMMUNSCHWÄCHE-VIRUS (HIV) IN VIVO

A method for inhibiting the activity of human immunodeficiency virus (HIV) in vivo comprises administering to a human host an antimalarial drug, which is capable of exhibiting a protective effect, a curative effect, or a preventing transmission of malaria in humans. The antimalarial drug is selected...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: DAVIS, MICHAEL H., SPRINGFIELD, MO., US
Format: Patent
Sprache:ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A method for inhibiting the activity of human immunodeficiency virus (HIV) in vivo comprises administering to a human host an antimalarial drug, which is capable of exhibiting a protective effect, a curative effect, or a preventing transmission of malaria in humans. The antimalarial drug is selected from the group consisting of (a) alkaloids; (b) 9-amino-acridines; (c) 4-aminoquinolines; (d) 8-aminoquinolines; (e) biguanides; (f) dihyrofolate reductase inhibitors; (g) sulfones; (h) sulfonamides; (i) mefloquine; (j) halofantrine; (k) hydroxyanilino-benzo-naphtyridines; and (l) sesquiterpene lactones. The antimalarial drug is administered to the human in an amount sufficient to prevent or at least inhibit infection of T lymphocytes by HIV in vivo or to prevent or at least inhibit replication of HIV in vivo.